30 Oct 2025

"Hogan Lovells Advises on Financing for Omega Pharma's Acquisition of Cieffe Derma"

"Global law firm Hogan Lovells advised BlackRock’s funds on a financing transaction to support Omega Pharma S.r.l. in acquiring Cieffe Derma S.r.l., a company specializing in dermocosmetics and food supplements. The transaction involved legal teams addressing both Italian and English law aspects, with Hogan Lovells also advising Loan Agency Services S.r.l. in its roles related to the debt facility."

Hogan Lovells and Loan Agency Services S.r.l. participated in the financing transaction, advising BlackRock’s funds and accounts and Omega Pharma S.r.l., as well as acting as Notes Trustee, Issuing Agent, Security Agent, and Noteholders' Representative. The transaction involved the financing aimed at the acquisition of Cieffe Derma S.r.l., a company specializing in the development and distribution of dermocosmetics and food supplements with a focus on dermatology and gynaecology. The acquisition was made by Omega Pharma S.r.l., a portfolio company of 21 Invest, from Azimut Libera Impresa SGR and the entrepreneurial family. The Hogan Lovells team advising BlackRock’s funds and accounts included partners Iacopo Canino and Bianca Caruso, senior associate Beatrice Bertuzzi, and associate Laura Leonelli. Partner Madeleine Horrocks and senior associate Franco Lambiase provided advice on English law aspects. Hogan Lovells also advised Loan Agency Services S.r.l. with a team led by partner Mauro Saccani and trainee Giovanni D’Apollo.
Read the full story

Register for free to access daily news.

Register Free
We use cookies to improve your experience, analyze traffic, and serve targeted ads. Read our Cookie Policy.

Cookie Preferences

Customize your cookie settings. Necessary cookies are always enabled.

Strictly Necessary

Required for the website to function (e.g. login, security).

Analytics & Statistics

Help us understand how visitors interact with the website.

Marketing & Ads

Used to deliver relevant ads and track effectiveness.